The Selling of Osteoporosis
If you are a midlife woman concerned about protecting your bone health and are unsure if a bisphosphonate drug such as Fosamax, Actonel or Boniva is the right choice for you, The Selling of Osteoporosis is a must read
As a pharmacist I advocate for the benefits of modern medicine, I also believe that for women to make good choices that protect their health, they need to understand the clear benefits and risks of their choices.
That is easier said than done. Much of the readily available consumer information about these products is fraught with misleading claims – at best and down right deceptive at worst. Drug information can be very confusing. The pharmaceutical industry doesn’t spend more on marketing than they do on research and development for no reason. Their ads are slick, powerful and convincing.
I intend for The Selling of Osteoporosis to serve as a starting point to help educate and guide you through the maze of health claims – as well as hidden dangers – of bisphosphonate drugs like Fosamax, Actonel and Boniva for preventing and treating osteoporosis. Without clear, factual, and understandable information women cannot make sound choices and decisions about their health.
In this report you’ll learn:
- The difference between osteoporosis and osteopenia.
- How to understand a bone density score.
- Important risk factors that contribute to the development of osteoporosis.
- The truth behind the claims that these drugs reduce hip fracture by 50%.
- Why even Doctors are not clear about the true benefits of these drugs.
- Why actual side effects to these drugs may be much higher and more debilitating than “official” data indicate.
Maintaining bone health isn’t a mystery, and it doesn’t have to be complicated. We’ll be following up soon with a free teleseminar with a panel of professionals who offer a practical program of self-care alternatives and advice for maintaining and strengthening bone health.
In the meantime, leave your name and email below to receive your free report and to keep posted on news of our upcoming teleseminar. You’ll also receive our monthly newsletter.

